Novo Nordisk launches once-daily Wegovy weight-loss pill in the US; cost ranges from $199-$299 a month
Novo Nordisk has launched the Wegovy pill in the US, offering a 1.5 mg starter dose of semaglutide, expanding its weight-loss treatment options. The pill, approved by the FDA, aims to regain market share against Eli Lilly's upcoming Mounjaro pill.
Novo Nordisk has launched the Wegovy pill in the US, offering a 1.5 mg starter dose of semaglutide, expanding its weight-loss treatment options. The pill, approved by the FDA, aims to regain market share against Eli Lilly's upcoming Mounjaro pill.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
